{
"id":"mk19_bb_gi_s17",
"subspecialtyId":"gi",
"title":"Inflammatory Bowel Disease",
"jsonContent":{
"type":"section",
"id":"mk19_bb_gi_s17",
"title":{
"__html":"Inflammatory Bowel Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"872e18",
"children":[
"Inflammatory Bowel Disease"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_gi_s17_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"295de4",
"children":[
"The two most common ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"inflammatory bowel disease",
"children":[
"IBD"
]
},
"s"
]
},
" are Crohn disease and ulcerative colitis, both of which cause macroscopic inflammation. Microscopic colitis does not cause significant macroscopic abnormalities."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_gi_s17_inline_t1"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"65ca95",
"children":[
"The most common extraintestinal manifestations are arthralgia, back pain (indicating ankylosing spondylitis or sacroiliitis), and oral aphthous ulcers. Eye redness, pain, and swelling may result from uveitis, iritis, or episcleritis. Skin manifestations include pyoderma gangrenosum and erythema nodosum. Liver involvement suggests ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"primary sclerosing cholangitis",
"children":[
"PSC"
]
},
"."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gi_s17_2",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"0a814f",
"children":[
"Colonoscopy and biopsy confirm the diagnosis. Stool studies are indicated for ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Shigella"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Salmonella"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Campylobacter"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Escherichia coli"
]
},
" O157:H7, ova and parasites, and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"C. difficile"
]
},
" toxin, especially if symptoms are acute. Fecal calprotectin should be considered to help differentiate between IBD and ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"irritable bowel syndrome",
"children":[
"IBS"
]
},
"."
]
}
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"731d9d",
"children":[
"Do not perform a barium enema examination in patients with moderate to severe ulcerative colitis because this procedure may precipitate toxic megacolon."
]
},
" ",
{
"type":"list-item",
"hlId":"95d6c0",
"children":[
"In patients with Crohn disease and cystitis, consider the possibility of enterovesical fistula."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gi_s17_3",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"296027",
"children":[
"Patients with IBD should receive seasonal influenza and either the 20-valent pneumococcal conjugate vaccine (PCV20) alone or the 15-valent pneumococcal conjugate vaccine (PCV15) followed by the 23-valent pneumococcal polysaccharide vaccine (PPSV23). Ideally, pneumococcal vaccination should occur before beginning immunosuppressive therapy."
]
},
{
"type":"p",
"hlId":"ebe2a4",
"children":[
"Treatment of Crohn disease and ulcerative colitis is divided into active and maintenance strategies. Specific treatment choices depend on the type, extent, and severity of the disease."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_bb_gi_s17_inline_t2"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"535c5a",
"children":[
"The level of thiopurine methyltransferase should be checked before starting azathioprine or ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"6-mercaptopurine",
"children":[
"6-MP"
]
},
";"
]
},
" enzyme deficiency leads to increased levels of azathioprine and 6-MP, so these should not be used or dosages should be adjusted."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gi_s17_4",
"title":{
"__html":"Follow-up Surveillance"
},
"titleNode":{
"type":"section-title",
"hlId":"3af103",
"children":[
"Follow-up Surveillance"
]
},
"children":[
{
"type":"p",
"hlId":"0ebc24",
"children":[
"Beginning 8-10 years after diagnosis, surveillance colonoscopy for dysplasia should be performed every 1 to 5 years for patients with IBD and immediately on diagnosis of PSC."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"163cd5",
"children":[
"Before initiating an ",
{
"type":"abbreviation",
"title":"anti–tumor necrosis factor",
"children":[
"anti-TNF"
]
},
" agent, all patients should be evaluated for ",
{
"type":"abbreviation",
"title":"tuberculosis",
"children":[
"TB"
]
},
" and hepatitis B and C virus infections."
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_bb_gi_f04"
],
"forceOpen":true
}
]
}
]
},
"tablesContent":{
"mk19_bb_gi_s17_inline_t1":{
"id":"mk19_bb_gi_s17_inline_t1",
"number":1,
"bookId":"gi",
"title":{
"__html":"Study Table: Differentiating Ulcerative Colitis from Crohn Disease"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"f36cd7",
"children":[
"Study Table: Differentiating Ulcerative Colitis from Crohn Disease"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"179d78",
"class":"col hd l",
"children":[
"Ulcerative Colitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9dfdf2",
"class":"col hd l",
"children":[
"Crohn Disease"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f23d60",
"class":"cell txt l",
"children":[
"Mucosal edema, erythema, and loss of the vascular pattern; granularity; friability; ulceration; and bleeding"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7f78dc",
"class":"cell txt l",
"children":[
"Linear, stellate, or serpiginous ulcerations with “skip” areas of inflammation involving entire ",
{
"type":"abbreviation",
"title":"gastrointestinal",
"children":[
"GI"
]
},
" tract"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b4cef9",
"class":"cell txt l",
"children":[
"Altered crypt architecture with shortened, branched crypts and crypt abscesses"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ebee83",
"class":"cell txt l",
"children":[
"Granulomas are characteristic but are often not found. Transmural involvement."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b99cc9",
"class":"cell txt l",
"children":[
"Diarrhea (prominent), tenesmus, urgency hematochezia, weight loss, and fever"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7d2f05",
"class":"cell txt l",
"children":[
"Abdominal pain (prominent), diarrhea, inflammatory masses, fever, weight loss, intestinal strictures and fistula"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"889aa3",
"class":"cell txt l",
"children":[
"Smoking alleviates symptoms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"45ee09",
"class":"cell txt l",
"children":[
"Smoking is a risk factor for disease"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_gi_s17_inline_t2":{
"id":"mk19_bb_gi_s17_inline_t2",
"number":2,
"bookId":"gi",
"title":{
"__html":"Study Table: Medical Treatment of Inflammatory Bowel Disease"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"87444b",
"children":[
"Study Table: Medical Treatment of Inflammatory Bowel Disease"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8d5233",
"class":"col hd l",
"children":[
"Disease Activity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"179d78",
"class":"col hd l",
"children":[
"Ulcerative Colitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9dfdf2",
"class":"col hd l",
"children":[
"Crohn Disease"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d14fbc",
"class":"cell txt l",
"children":[
"Mild"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4a78e5",
"class":"cell txt l",
"children":[
"Oral and topical ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"5-aminosalicylate",
"children":[
"5-ASA"
]
},
"s"
]
},
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"e6c1fb",
"class":"cell txt l",
"children":[
"Steroid suppository and enema",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" ",
{
"type":"p",
"hlId":"9b6832",
"class":"cell txt l",
"children":[
"Multimatrix budesonide"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"af7245",
"class":"cell txt l",
"children":[
"Sulfasalazine for colitis",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"106a8b",
"class":"cell txt l",
"children":[
"Budesonide for ileocolonic disease",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1eb79d",
"class":"cell txt l",
"children":[
"Moderate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4a78e5",
"class":"cell txt l",
"children":[
"Oral and topical 5-ASAs",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"015393",
"class":"cell txt l",
"children":[
"Azathioprine/6-MP",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" ",
{
"type":"p",
"hlId":"7568b2",
"class":"cell txt l",
"children":[
"Multimatrix budesonide and oral glucocorticoids",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" ",
{
"type":"p",
"hlId":"6c5f67",
"class":"cell txt l",
"children":[
"Biologic agents (infliximab, adalimumab, golimumab, vedolizumab, ustekinumab)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"7955b9",
"class":"cell txt l",
"children":[
"Tofacitinib",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d95f7f",
"class":"cell txt l",
"children":[
"Oral and intravenous glucocorticoids",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" ",
{
"type":"p",
"hlId":"106a8b",
"class":"cell txt l",
"children":[
"Budesonide for ileocolonic disease",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" ",
{
"type":"p",
"hlId":"015393",
"class":"cell txt l",
"children":[
"Azathioprine/6-MP",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" ",
{
"type":"p",
"hlId":"e8a533",
"class":"cell txt l",
"children":[
"Methotrexate",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" ",
{
"type":"p",
"hlId":"978642",
"class":"cell txt l",
"children":[
"Biologic agents (infliximab, adalimumab, certolizumab, vedolizumab, natalizumab, ustekinumab)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a6b2b9",
"class":"cell txt l",
"children":[
"Severe"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2f11c0",
"class":"cell txt l",
"children":[
"Oral or intravenous glucocorticoids",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" ",
{
"type":"p",
"hlId":"c1964f",
"class":"cell txt l",
"children":[
"Cyclosporine",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" ",
{
"type":"p",
"hlId":"6c5f67",
"class":"cell txt l",
"children":[
"Biologic agents (infliximab, adalimumab, golimumab, vedolizumab, ustekinumab)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"7955b9",
"class":"cell txt l",
"children":[
"Tofacitinib",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2f11c0",
"class":"cell txt l",
"children":[
"Oral or intravenous glucocorticoids",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" ",
{
"type":"p",
"hlId":"d3134e",
"class":"cell txt l",
"children":[
"Biologic agents (infliximab, adalimumab, certolizumab, vedolizumab, ustekinumab)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Remission and maintenance."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Remission."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Maintenance, glucocorticoid-sparing."
]
]
}
}
}